2009.11.23 Weekly Broadcast Email
We are considering a concept using a highly purified ginger preparation to treat chemotherapy induced nausea. The investigators proposing the concept have several questions they would appreciate you answering to help with study design. The questions are:
1) would you be willing to enter a patient on a study using this highly purified ginger preparation as primary anti-emetic prophylaxis instead of conventional anti-emetics?
2) would you be willing to randomize a patient who failed standard primary anti-emetic prophylaxis on a study of second line anti-emetic prophylaxis with or without the highly purified ginger preparation?
Thanks in advance for your response.
Dr. Ed Shaw, Research Base PI
There were no updates made the website for the week of November 23, 2009.
The CCCWFU CCOP Research Base offices will be closed November 24 and 25 for the Thanksgiving holiday.
97106 (Randomized Study to Determine whether ArginMax Improves the Sexual Function and Quality of Life in Female Cancer Survivors) only has 8 minority accrual slots open for patient accruals. We would like to see this study close by the end of the year, so if you have patients that may be eligible for this study, please try and get them registered by then.